SCHEMBL20205465

SCHEMBL20205465

CC1(C)c2cc3c(cc2-c2c1cc(-c1cc4ccccc4o1)c1oc4ccccc4c21)C(C)(C)c1cc(-c2cc4ccccc4o2)c2oc4ccccc4c2c1-3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ MAOB P27338 2/20 0.40
▸ MAOA P21397 1/20 0.40
▸ POLB P06746 3/20 0.38
▸ CTDSP1 Q9GZU7 1/20 0.38
▸ RAB9A P51151 2/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ IKBKB O14920 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205435 0.95 KMT2A (0.38) KMT2AMEN1TDP1MAOBMAOA
SCHEMBL20205721 0.91 MAOB (0.38) KMT2AMEN1TDP1MAOBMAOA
SCHEMBL20205724 0.90 KMT2A (0.40) KMT2AMEN1TDP1MAOBMAOA
SCHEMBL20205711 0.87 MAOB (0.35) KMT2AMEN1TDP1MAOBMAOA
SCHEMBL20205397 0.84 PGR (0.33) KMT2AMEN1TDP1MAOAALDH1A1
SCHEMBL20205469 0.84 MAOA (0.36) KMT2AMEN1TDP1MAOBMAOA
SCHEMBL20205460 0.83 MAOB (0.41) KMT2AMEN1TDP1MAOBMAOA
SCHEMBL15895872 0.83 KMT2A (0.44) KMT2AMEN1TDP1MAOBMAOA
SCHEMBL20205335 0.83 CDC14B (0.40) KMT2AMEN1RAB9ACYP1A1CYP1B1
SCHEMBL20205630 0.83 ALOX5 (0.36) KMT2AMEN1TDP1MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND KMT2A 3354/4885MEN1 3856/4885TDP1 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback